Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
Status:
Recruiting
Trial end date:
2022-12-07
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well megestrol acetate with or without pterostilbene works in
treating patients with endometrial cancer undergoing hysterectomy. Drugs used in
chemotherapy, such as megestrol acetate, work in different ways to stop the growth of tumor
cells, either by killing the cells, by stopping them from dividing, or by stopping them from
spreading. Pterostilbene is an antioxidant found in blueberries or grapes, and it has been
shown to be effective in killing tumor cells and reducing cancer burden. It is not yet known
whether giving megestrol acetate with or without pterostilbene may work better in treating
patients with endometrial cancer.